772 related articles for article (PubMed ID: 25792129)
1. Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation.
Wakui H; Uneda K; Tamura K; Ohsawa M; Azushima K; Kobayashi R; Ohki K; Dejima T; Kanaoka T; Tsurumi-Ikeya Y; Matsuda M; Haruhara K; Nishiyama A; Yabana M; Fujikawa T; Yamashita A; Umemura S
J Am Heart Assoc; 2015 Mar; 4(3):e001594. PubMed ID: 25792129
[TBL] [Abstract][Full Text] [Related]
2. Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension.
Wakui H; Tamura K; Masuda S; Tsurumi-Ikeya Y; Fujita M; Maeda A; Ohsawa M; Azushima K; Uneda K; Matsuda M; Kitamura K; Uchida S; Toya Y; Kobori H; Nagahama K; Yamashita A; Umemura S
Hypertension; 2013 Jun; 61(6):1203-10. PubMed ID: 23529167
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension.
Ohsawa M; Tamura K; Wakui H; Maeda A; Dejima T; Kanaoka T; Azushima K; Uneda K; Tsurumi-Ikeya Y; Kobayashi R; Matsuda M; Uchida S; Toya Y; Kobori H; Nishiyama A; Yamashita A; Ishikawa Y; Umemura S
Kidney Int; 2014 Sep; 86(3):570-81. PubMed ID: 24694992
[TBL] [Abstract][Full Text] [Related]
4. An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model.
Kobayashi R; Wakui H; Azushima K; Uneda K; Haku S; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Ohsawa M; Toya Y; Nishiyama A; Yamashita A; Tanabe K; Maeshima Y; Umemura S; Tamura K
Kidney Int; 2017 May; 91(5):1115-1125. PubMed ID: 28081856
[TBL] [Abstract][Full Text] [Related]
5. Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice.
Wakui H; Tamura K; Matsuda M; Bai Y; Dejima T; Shigenaga A; Masuda S; Azuma K; Maeda A; Hirose T; Ishigami T; Toya Y; Yabana M; Minamisawa S; Umemura S
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F991-F1003. PubMed ID: 20739392
[TBL] [Abstract][Full Text] [Related]
6. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
Dejima T; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Haku S; Kengo A; Masuda S; Shigenaga A; Azuma K; Matsuda M; Yabana M; Hirose T; Uchino K; Kimura K; Nagashima Y; Umemura S
J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
[TBL] [Abstract][Full Text] [Related]
7. ATRAP, a receptor-interacting modulator of kidney physiology, as a novel player in blood pressure and beyond.
Tamura K; Azushima K; Kinguchi S; Wakui H; Yamaji T
Hypertens Res; 2022 Jan; 45(1):32-39. PubMed ID: 34642449
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II Type 1 Receptor Binding Molecule ATRAP as a Possible Modulator of Renal Sodium Handling and Blood Pressure in Pathophysiology.
Tamura K; Wakui H; Azushima K; Uneda K; Haku S; Kobayashi R; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Yamashita A; Umemura S
Curr Med Chem; 2015; 22(28):3210-6. PubMed ID: 26295465
[TBL] [Abstract][Full Text] [Related]
9. Expression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy.
Masuda S; Tamura K; Wakui H; Maeda A; Dejima T; Hirose T; Toyoda M; Azuma K; Ohsawa M; Kanaoka T; Yanagi M; Yoshida S; Mitsuhashi H; Matsuda M; Ishigami T; Toya Y; Suzuki D; Nagashima Y; Umemura S
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F720-31. PubMed ID: 20685825
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II Type 1 Receptor-Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin.
Uneda K; Wakui H; Maeda A; Azushima K; Kobayashi R; Haku S; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Ohsawa M; Minegishi S; Ishigami T; Toya Y; Atobe Y; Yamashita A; Umemura S; Tamura K
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751545
[TBL] [Abstract][Full Text] [Related]
11. Effects of ATRAP in Renal Proximal Tubules on Angiotensin-Dependent Hypertension.
Kinguchi S; Wakui H; Azushima K; Haruhara K; Koguchi T; Ohki K; Uneda K; Matsuda M; Haku S; Yamaji T; Yamada T; Kobayashi R; Minegishi S; Ishigami T; Yamashita A; Fujikawa T; Tamura K
J Am Heart Assoc; 2019 Apr; 8(8):e012395. PubMed ID: 30977419
[TBL] [Abstract][Full Text] [Related]
12. Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.
Wakui H; Dejima T; Tamura K; Uneda K; Azuma K; Maeda A; Ohsawa M; Kanaoka T; Azushima K; Kobayashi R; Matsuda M; Yamashita A; Umemura S
Cardiovasc Res; 2013 Dec; 100(3):511-9. PubMed ID: 24189624
[TBL] [Abstract][Full Text] [Related]
13. miR-125a-5p/miR-125b-5p contributes to pathological activation of angiotensin II-AT1R in mouse distal convoluted tubule cells by the suppression of Atrap.
Hirota K; Yamashita A; Abe E; Yamaji T; Azushima K; Tanaka S; Taguchi S; Tsukamoto S; Wakui H; Tamura K
J Biol Chem; 2023 Dec; 299(12):105478. PubMed ID: 37981211
[TBL] [Abstract][Full Text] [Related]
14. Collecting duct prorenin receptor knockout reduces renal function, increases sodium excretion, and mitigates renal responses in ANG II-induced hypertensive mice.
Prieto MC; Reverte V; Mamenko M; Kuczeriszka M; Veiras LC; Rosales CB; McLellan M; Gentile O; Jensen VB; Ichihara A; McDonough AA; Pochynyuk OM; Gonzalez AA
Am J Physiol Renal Physiol; 2017 Dec; 313(6):F1243-F1253. PubMed ID: 28814438
[TBL] [Abstract][Full Text] [Related]
15. Renal transporter activation during angiotensin-II hypertension is blunted in interferon-γ-/- and interleukin-17A-/- mice.
Kamat NV; Thabet SR; Xiao L; Saleh MA; Kirabo A; Madhur MS; Delpire E; Harrison DG; McDonough AA
Hypertension; 2015 Mar; 65(3):569-76. PubMed ID: 25601932
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity.
Maeda A; Tamura K; Wakui H; Dejima T; Ohsawa M; Azushima K; Kanaoka T; Uneda K; Matsuda M; Yamashita A; Miyazaki N; Yatsu K; Hirawa N; Toya Y; Umemura S
J Am Heart Assoc; 2013 Jul; 2(4):e000312. PubMed ID: 23902639
[TBL] [Abstract][Full Text] [Related]
17. The pathophysiological role of angiotensin receptor-binding protein in hypertension and kidney diseases: Oshima Award Address 2019.
Wakui H
Clin Exp Nephrol; 2020 Apr; 24(4):289-294. PubMed ID: 32112267
[TBL] [Abstract][Full Text] [Related]
18. Renal arteriolar injury by salt intake contributes to salt memory for the development of hypertension.
Oguchi H; Sasamura H; Shinoda K; Morita S; Kono H; Nakagawa K; Ishiguro K; Hayashi K; Nakamura M; Azegami T; Oya M; Itoh H
Hypertension; 2014 Oct; 64(4):784-91. PubMed ID: 24980670
[TBL] [Abstract][Full Text] [Related]
19. PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension.
Berger JM; Vaillant N; Le May C; Calderon C; Brégeon J; Prieur X; Hadchouel J; Loirand G; Cariou B
Atherosclerosis; 2015 Mar; 239(1):252-9. PubMed ID: 25621930
[TBL] [Abstract][Full Text] [Related]
20. Influence of angiotensin II type 1 receptor-associated protein on prenatal development and adult hypertension after maternal dietary protein restriction during pregnancy.
Tsukuda K; Mogi M; Iwanami J; Min LJ; Jing F; Ohshima K; Horiuchi M
J Am Soc Hypertens; 2012; 6(5):324-30. PubMed ID: 22951100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
